Immuron reports delay in Travelan study data
Source: SeekingAlpha
2025-10-31 09:36:53 ET
More on Immuron
Read the full article on Seeking Alpha
For further details see:
Immuron reports delay in Travelan study data
Immuron Limited
NASDAQ: IMRN
IMRN Trading
-2.07% G/L:
$1.14 Last:
53,260 Volume:
$1.21 Open:
IMRN Latest News
July 06, 2026 06:00:00 am
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
March 05, 2026 06:00:00 am
Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference
$5,297,344
6,340,720
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
AU
Carlton South
